Off-Label Use of Neovasculgen for II-III Degree Foot Frostbite: A Case Report
INTRODUCTION. The high mortality and disability rates associated with cold injury are often a consequence of urgent amputation or disarticulation surgery. The use of the Russian gene therapy product Neovasculgen can decrease the amputation rate in patients with chronic limb ischaemia through prevent...
Сохранить в:
Главные авторы: | , , , , , , , , |
---|---|
Формат: | |
Опубликовано: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»,
2022-03-01T00:00:00Z.
|
Предметы: | |
Online-ссылка: | Connect to this object online. |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Internet
Connect to this object online.3rd Floor Main Library
Шифр: |
A1234.567 |
---|---|
Копировать 1 | Доступно |